National Ovarian Cancer Awareness Month

September is National Ovarian Cancer Awareness Month. Britt Erickson, MD, an Assistant Professor with the Department of Obstetrics, Gynecology and Women’s Health (OBGYN) covered the topic.

Ovarian cancer is a disease process that originates from either the surface of the ovary, fallopian tube or the lining of the abdominal cavity. Cells become abnormal and then multiply, forming tumors that ultimately spread to other parts of the abdomen.

Certain groups of women are at higher risk of developing ovarian cancer, including those with a strong family history of ovarian cancer or with a genetic mutation (such as a BRCA mutation) in their DNA that predisposes them. For women with a known genetic mutation, prophylactic surgery — removing the tubes and ovaries — is recommended and should be discussed with their doctor. 

Symptoms of ovarian cancer include bloating, abdominal distention and feeling full. Unfortunately, there is no screening test for ovarian cancer. It is not usually discovered through a pelvic exam or Pap smear, which is why most women with ovarian cancer have more advanced (stage 3 or 4) disease. It can be detected by imaging (either ultrasound, CT scan or MRI) and confirmed with a biopsy or surgery. 

Once diagnosed with ovarian cancer, most patients receive a combination of chemotherapy and surgery. The goal of treatment is for women to go into remission and become cancer-free. This happens more than 50% of the time, but ovarian cancer recurrence rates are high, meaning many women do ultimately die from it.

Erickson noted, “The University of Minnesota has many clinical trials open for women at various stages of their cancer treatment. The goal of these trials is to determine if new therapies are better than existing treatments. For example, we have a trial open examining the effects of immunotherapy, specifically Natural Killer cells, in women with recurrent ovarian cancer.”

Clinicians and researchers are using blood samples and Pap smears to evaluate for proteins that may be more common in women with ovarian cancer, hoping to one day develop a screening test. The Medical School will continue to conduct research and train medical students, residents and gynecologic oncology fellows to learn more about how to take care of women with ovarian cancer.

Share this post

Related News

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”

  • OBGYN Professor Trains Medical School Learners to Identify PCOS

    PCOS, or polycystic ovary syndrome, remains largely undiagnosed. Sarah Hutto, MD, in the Department of Obstetrics, Gynecology and Women’s Health, dedicates her instruction time with medical students and residents on how to identify early warning signs of PCOS and properly evaluate and diagnose the condition before it worsens.

  • Family Medicine Student Interest Group Earns National Award

    The Family Medicine Student Interest Group, at the University of Minnesota Medical School, Duluth Campus was recognized by the American Academy of Family Physicians as the 2020 Program of Excellence for exemplary efforts to grow and support interest in family medicine practice.